4 big analyst cuts: Farfetch downgraded on disappointing Q2, Cigna slashed to Hold

Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: Downgrades at Farfetch, Cigna, Keysight Technologies, and XPO.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

Farfetch downgraded, following disappointing Q2

KeyBanc downgraded Farfetch (NYSE:) to Sector Weight from Overweight following disappointing , which resulted in more than a 37% stock price drop pre-market today.

Q2 came in at $579.35 million (down 1.3% year-over-year), missing the consensus estimate of $648.27M. Meanwhile, EPS was ($0.21), compared to the consensus of ($0.28). For the full 2023 year, the company expects revenue of $2.5 billion, worse than the consensus estimate of $2.8B.

According to KeyBanc, the rating change is based on decreased confidence in execution and the timeline to profitability. Factors such as macroeconomic challenges and a decline in Brand Platform GMV by 42% year-over-year had a negative impact on the quarter’s results. Additionally, softened expectations for Reebok’s performance, as well as year-over-year declines in the U.S. and China, increase the risk of achieving profitability in fiscal 2023.

Though we view cost rationalization initiatives positively, we think reduced guidance implies a fairly tough 2H hurdle given softer trends. We continue to like FTCH’s LT potential but are downgrading it to Sector Weight based on decreased confidence in execution/heightened risk to FY23 profitability and MT targets.

Cigna slashed to Hold

Edward Jones downgraded Cigna (NYSE:) to Hold from Buy, as reported in real-time on InvestingPro.

Earlier this month, the company reported its Q2 , with EPS and revenues coming in better than the consensus estimates. However, full-year revenue guidance came in below expectations.

Two more downgrades

Barclays downgraded Keysight Technologies (NYSE:) to Equalweight from Overweight and cut its price target to $144.00 from $204.00, following the company’s Q3 announcement yesterday.

While Q3 EPS came in above the consensus estimates and revenues were in line with expectations, Q4 guidance was worse than expected, which resulted in a share price drop of more than 11% pre-market today.

XPO (NYSE:) shares fell more than 1% pre-market today after Loop Capital downgraded the company to Hold from Buy with a price target of $74.00 (from $55.00).

Get ready to supercharge your investment strategy with our exclusive discounts.

Don’t miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won’t last forever!